Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The main purpose of this study is to compare the incidence of contrast induced nephrotoxicity following the administration of Isovue (iopamidol) or Visipaque in diabetic patients with moderate to severe chronic renal impairment undergoing clinically indicated contrast enhanced multidetector computed tomography (MDCT). Serum creatinine will be measured before and up to 48-72 hours post dose.
Epistemonikos ID: b83cc646dfe102a4fb20c3ac9a53fee8175693a2
First added on: May 04, 2024